Hélène Jonathan Rémi Danielou Lebreton Vatan

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

E. Vicaut, S. Rebaudet, M. Briet, 2021, Clinical Microbiology and Infection.